Buscar
Mostrando ítems 21-30 de 3572
Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?
(Wiley, 2014)
Diabetes mellitus is a complex metabolic disease that has become a global epidemic with more than 285 million cases worldwide. Major medical advances over the past decades have substantially improved its management, extending ...
Mesenchymal stromal cells in ischemic brain injury
(MDPI, 2022-03-01)
Ischemic brain injury represents a major cause of death worldwide with limited treatment options with a narrow therapeutic window. Accordingly, novel treatments that extend the treatment from the early neuroprotective stage ...
Viability of Fibrin Sealant from Snake Venom as Scaffold to Rat Marrow-Derived Mesenchymal Stem Cells
(Pergamon-Elsevier B.V. Ltd, 2012-08-01)
Differentiation of human mesenchymal stem cells through the natural matrix to neurospheres for cholinergic-like cells
(Oxford Univ Press, 2021-08-01)
Viability of Fibrin Sealant from Snake Venom as Scaffold to Rat Marrow-Derived Mesenchymal Stem Cells
(Pergamon-Elsevier B.V. Ltd, 2012-08-01)
Chondrogenic Differentiation of Bone Marrow Mesenchymal Stem Cells: First Successful Latin-American Report
(Sociedad Chilena de Anatomía, 2010)
Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?
(2015)
Multipotent mesenchymal stromal cells [also referred to as mesenchymal stem cells (MSCs)] are a heterogeneous subset of stromal cells. They can be isolated from bone marrow and many other types of tissue. MSCs are currently ...
Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus.
(Fernando Ezquer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited., 2015)
The aim of our work was to evaluate, in an animal model of severe diabetes mellitus, the effect of mesenchymal stem cells (MSCs) administration on diabetic nephropathy (DN) progression. After diabetes induction, one group ...